Multiple Applications For Replication‐Defective Herpes Simplex Virus Vectors
- 1 September 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 19 (5), 358-377
- https://doi.org/10.1634/stemcells.19-5-358
Abstract
Herpes simplex virus (HSV) is a neurotropic DNA virus. The viral genome is large (152 kb), and many genes are dispensable for viral function, allowing insertion of multiple or large transgene expression cassettes. The virus life cycle includes a latent phase, during which the viral genome remains as a stable episomal element within neuronal nuclei for the lifetime of the host, without disturbing normal function. We have exploited these features of HSV to construct a series of nonpathogenic gene therapy vectors that efficiently deliver therapeutic and experimental transgenes to neural and non-neural tissue. Importantly, transgene expression may be sustained long term; reporter gene expression has been demonstrated for over a year in the nervous system. This article discusses the generation of replication-defective HSV vectors and reviews recent studies investigating their use in several animal models of human disease. We have demonstrated correction or prevention of a number of important neurological phenotypes, including neurodegeneration, chronic pain, peripheral neuropathy, and malignancy. In addition, HSV-mediated transduction of non-neurological tissues allows their use as depot sites for synthesis of circulating and locally acting secreted proteins. New applications for this vector system include the genetic modification of stem cell populations; this may become an important means to direct cellular differentiation or deliver therapeutic genes systemically. Replication-defective HSV vectors are an effective and flexible vehicle for the delivery of transgenes to numerous tissues, with multiple applications.Keywords
This publication has 208 references indexed in Scilit:
- Herpesvirus-Mediated Systemic Delivery of Nerve Growth FactorMolecular Therapy, 2001
- Gap junctions: the “kiss of death” and the “kiss of life”Brain Research Reviews, 2000
- Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus modelGene Therapy, 2000
- Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivoGene Therapy, 1999
- The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in ratsJournal of Neurosurgery, 1994
- A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequenceCell, 1988
- Latent Herpes Simplex Virus in Human Trigeminal GangliaNew England Journal of Medicine, 1987
- Influence of embedding media on DNA structure in herpes simplex virus type 1Biology of the Cell, 1985
- Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1Journal of Molecular Biology, 1985
- Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcriptionJournal of Molecular Biology, 1984